Fertility preservation is an emerging discipline, which is of substantial clinical value in the
care of young patients with cancer. Chemotherapy and radiation may induce ovarian …

Cancer treatment, such as chemotherapy, induces early ovarian follicular depletion and
subsequent infertility. In order to protect gametes from the gonadotoxic effects of …

Highlights•These ESMO Clinical Practice Guidelines provide recommendations for:○Fertility
preservation strategies in post-pubertal cancer patients, including those with hereditary …

PURPOSE Nonadherence to long-term treatments is often under-recognized by physicians
and there is no gold standard for its assessment. In breast cancer, nonadherence to …

Background Healthy individuals and patients with cancer who are carriers of germline
pathogenic variants in the BRCA1/2 genes face multiple reproductive challenges that …

The only clinically accepted method of fertility preservation in young women facing
gonadotoxic chemo-and/or radiotherapy for malignant or autoimmune diseases is …

Background Although use of gonadotropin-releasing hormone agonist (GnRHa) during
chemotherapy is an established strategy to protect ovarian function in premenopausal …

In recent years, ovarian tissue cryopreservation has rapidly developed as a successful
method for preserving the fertility of girls and young women with cancer or benign conditions …

Due to improvements in chemotherapeutic agents, cancer treatment efficacy and cancer
patient survival rates have greatly improved, but unfortunately gonadal damage remains a …

Oncofertility is a new interdisciplinary field at the intersection of oncology and reproductive
medicine that expands fertility options for young cancer patients. The most common forms of …